Cargando…
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Non-alcoholic fatty liver disease (NAFLD) affects about 24% of the world's population. Progression of early stages of NAFLD can lead to the more advanced form non-alcoholic steatohepatitis (NASH), and ultimately to cirrhosis or liver cancer. The current gold standard for diagnosis and assessmen...
Autores principales: | Heinemann, Fabian, Gross, Peter, Zeveleva, Svetlana, Qian, Hu Sheng, Hill, Jon, Höfer, Anne, Jonigk, Danny, Diehl, Anna Mae, Abdelmalek, Manal, Lenter, Martin C., Pullen, Steven S., Guarnieri, Paolo, Stierstorfer, Birgit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649648/ https://www.ncbi.nlm.nih.gov/pubmed/36357500 http://dx.doi.org/10.1038/s41598-022-23905-3 |
Ejemplares similares
-
Deep learning enables pathologist-like scoring of NASH models
por: Heinemann, Fabian, et al.
Publicado: (2019) -
Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017) -
The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018) -
Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020) -
Whole‐Exome Sequencing Study of Extreme Phenotypes of NAFLD
por: Kleinstein, Sarah E., et al.
Publicado: (2018)